Budget 2026 wishlist: Pharma industry seeks higher tax credits, faster approvals, R&D incentives

Indian pharma leaders are urging the government for increased research and development incentives in the upcoming Union budget. They seek stronger tax credits and support for drug discovery to drive innovation and growth. Faster regulatory pathways and digitalization are also crucial. Industry aims for significant growth by 2030 and 2047, emphasizing a shift towards an innovation-led sector.